Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

60

Number of overlapping holdings

18.6%

% of FHLC's 349 holdings also in XLV

100.0%

% of XLV's 60 holdings also in FHLC

Overlap by Weight
Sector Drift (FHLC minus XLV)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in FHLC
Weight
in XLV
Overlap
ELI LILLY & CO 11.3% 12.3% 11.3%
UNITEDHEALTH GROUP INC 7.3% 9.0% 7.3%
JOHNSON & JOHNSON 6.4% 7.5% 6.4%
ABBVIE INC 6.1% 6.9% 6.1%
MERCK & CO. INC. 3.8% 4.3% 3.8%

Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XLV
VEEVA SYSTEMS INC-CLASS A 0.6%
ALNYLAM PHARMACEUTICALS INC 0.5%
NATERA INC 0.3%
ILLUMINA INC 0.2%
BIOMARIN PHARMACEUTICAL INC 0.2%
UNITED THERAPEUTICS CORP 0.2%
INSMED INC 0.2%
TENET HEALTHCARE CORP 0.2%
ROYALTY PHARMA PLC CLASS A 0.2%
INTRA-CELLULAR THERAPIES INC 0.2%
FHLC Underweight Relative to XLV
UNITEDHEALTH GROUP INC -1.7%
JOHNSON & JOHNSON -1.0%
ELI LILLY & CO -1.0%
ABBVIE INC -0.8%
ABBOTT LABORATORIES -0.5%
MERCK & CO. INC. -0.4%
BOSTON SCIENTIFIC CORP -0.4%
ELEVANCE HEALTH INC -0.4%
VERTEX PHARMACEUTICALS INC -0.4%
THERMO FISHER SCIENTIFIC INC -0.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY